Last update Aug. 12, 2014

Idoxuridine Ophtalmic Use

Very Low Risk

Safe. Compatible. Minimal risk for breastfeeding and infant.

Anti-Herpes drug that is exclusive topically used. Like most ophthalmologic compounds for topical use a low dose and poor absorption make it compatible with breastfeeding. Not commercially available in Spain

Alternatives

We do not have alternatives for Idoxuridine Ophtalmic Use since it is relatively safe.

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Group

Idoxuridine Ophtalmic Use belongs to this group or family:

Pharmacokinetics

Variable Value Unit
Molecular weight 429 daltons

References

  1. WHO / UNICEF. BREASTFEEDING AND MATERNAL MEDICATION Recommendations for Drugs in the Eleventh WHO Model List of Essential Drugs. Department of Child and Adolescent Health and Development (WHO/UNICEF) 2002 Abstract Full text (link to original source) Full text (in our servers)

Total visits

3,360

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by El Parto Es Nuestro of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM